Automate the wet lab.

Scale scientific judgment.

Analytical review takes hours or days, a bottleneck in an increasingly automated lab. EI’s foundational model applies your scientists’ judgment as a governed standard wherever the method runs, compressing development time and increasing confidence in every decision.

A unique AI architecture designed to be developed by your scientists.

EI’s Limited Sample Model (LSM) is the foundational technology driving the whole platform. Shaped by the constraints of the lab and the requirements of the scientists, it delivers accuracy, consistency, and governance in regulated environments.

The bottleneck, cleared end to end.

EI Flow analytical workflow, a lab bench from sample prep through to signed reports

One platform.
Every result connected.

Three layers turn validated evidence from across your labs into a continuous understanding of each program, so every new result informs what comes next from design through manufacturing.

Judgment.


EI Flow deploys that governed judgment wherever the method runs, across internal labs and partner sites. Routine review is automated in parallel, while the scientists who created the model can review exceptions remotely and direct further refinement from one place.

Oversight.


EI Signal builds on the continuous stream of governed decisions created by EI Flow, weaving them across instruments, workflows, studies, and labs over time. Patterns, drift, and dependencies become visible at every level, turning scientific judgment into intelligence across the organization.

Action.


Model Context Protocol (MCP) allows authorized people, models, and systems to put that intelligence to work, from improving in silico design upstream to guiding manufacturing and quality downstream. When those actions produce new laboratory results, EI reads that governed evidence, closing the loop while preserving the integrity of the scientific record.

Every long-term study is now watched as it runs. We catch a trend forming and act months before it could become a warning letter...

— Head of Quality, Global Pharmaceutical Company

Deploy where your data needs to live.

EI is vendor-agnostic and connects with the instruments, LIMS, and approved enterprise systems you already use without replacing your existing lab infrastructure. Deploy the platform according to your security, data-residency, and latency requirements. Your data remains within the environment you authorize and is never mixed across customers.

Cloud


A managed cloud deployment speeds implementation and scales access across laboratories and sites while maintaining governed security and availability.

Private Cloud


Run EI in dedicated cloud infrastructure aligned with your organization’s security, networking, and data-residency policies.

Hybrid


Place data and processing where each workflow requires while connecting instruments, laboratories, and enterprise systems across environments.

On-premises


Keep processing and data inside your controlled network when local latency, residency, or security requirements demand it.

Built for compliance and validation.

EI is designed for regulated laboratories where every electronic record, model change, and decision must remain secure, traceable, and defensible.

21 CFR Part 11


EI supports compliant electronic records and signatures with complete audit trails, controlled versions, traceability, and secure retention and archival. Every result remains connected to its source data, review history, and model version.

GxP readiness


EI supports GLP- and GMP-aligned workflows through risk-based computer system validation and GAMP 5 practices. IQ, OQ, and PQ documentation supports qualification, deployment, and controlled change.

SOC 2 Type II


Security, availability, and confidentiality controls are independently examined over time. Continuous monitoring, incident response, backup, and recovery protect the systems and data your laboratories depend on.

Data privacy and residency


Configurable residency and sovereignty controls keep data within approved environments. Encryption at rest and in transit and GDPR-aligned handling protect data across cloud, on-premises, and hybrid deployments.

Case Study

Case Study

Case Study

Frequently asked questions.

See it in action.

Request a demo and see how trusted results compress the time and cost of drug development.

A dashboard of data analysis showing a decision matrix with colored dots representing data points, some of which are marked as anomalies in red and orange. The left sidebar displays project information, task updates, and anomaly summaries.
A dashboard of data analysis showing a decision matrix with colored dots representing data points, some of which are marked as anomalies in red and orange. The left sidebar displays project information, task updates, and anomaly summaries.